Track-and-trace bill could be too costly, CBO report says

07/26/2013 | Securing Industry

A Senate bill to mandate lot-level track-and-trace for pharmaceuticals could go over cost limits for the private sector, according to a report from the Congressional Budget Office. The measure is expected to put a strain on pharmaceutical companies, which will need to pay fees, maintain transaction records for six years and verify transaction information. Wholesalers and third-party logistics providers for drug companies likely will pay about $35 million in fees, CBO estimates.

View Full Article in:

Securing Industry

Published in Brief:

SmartBrief Job Listings for Retail

Job Title Company Location
Product Manager
Smithsonian Museum Retail
Washington, Dist. Columbia
Mgr of Merchandising and Supply Chain Systems
BJ's Wholesale Club
Westborough, Massachusetts
communications program manager, Partner Resources-Seattle, WA
Seattle, Washington
director, mobile engineering, Global Technology - Seattle, WA
Seattle, Washington
Sr. Social Media Specialist
Columbus, Ohio